Article Details

AstraZeneca's Alexion halts ALS trial on lack of efficacy | SaltWire

Retrieved on: 2021-08-20 06:50:32

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's Alexion halts ALS trial on lack of efficacy | SaltWire. View article details on hiswai:

Excerpt

(Reuters) -AstraZeneca's Alexion division will stop developing a treatment for the neurological disorder ALS due to lack of efficacy in a late-stage trial, ...

Article found on: www.saltwire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up